Dr. Tanja A Gruber, MD, PhD
Claim this profileLucile Packard Children's Hospital Stanford University
Area of expertise
Acute Lymphoblastic Leukemia
Tanja A Gruber, MD, PhD has run 3 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Lymphoblastic Leukemia
Tanja A Gruber, MD, PhD has run 1 trial for Lymphoblastic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Lucile Packard Children's Hospital Stanford University
Stanford University
Clinical Trials Tanja A Gruber, MD, PhD is currently running
Talazoparib + Chemotherapy
for Acute Myeloid Leukemia
This trial is testing the safety of using talazoparib with standard chemotherapy in cancer patients. Talazoparib works by stopping cancer cells from repairing themselves, which could make chemotherapy more effective. The study aims to find the safest dose combination and see if this approach helps patients. Talazoparib is FDA approved for certain types of breast cancer that have spread and were previously treated with chemotherapy.
Recruiting
1 award
Phase 1
19 criteria
Palbociclib + Chemotherapy
for Acute Lymphoblastic Leukemia
With this research study has following goals * To confirm the highest tolerable dose of palbociclib in combination with chemotherapy is safe and well-tolerated. * To learn more about side effects of palbociclib in combination with chemotherapy; * To learn more about the biological effects of palbociclib on the cells in your body
Recruiting
3 awards
Phase 1
21 criteria
More about Tanja A Gruber, MD, PhD
Clinical Trial Related
10 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Tanja A Gruber, MD, PhD has experience with
- Blinatumomab
- Bortezomib
- Vorinostat
- Gemcitabine
- Talazoparib
- Topotecan
Breakdown of trials Tanja A Gruber, MD, PhD has run
Acute Lymphoblastic Leukemia
Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tanja A Gruber, MD, PhD specialize in?
Tanja A Gruber, MD, PhD focuses on Acute Lymphoblastic Leukemia and Lymphoblastic Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved KMT2Ar positive patients, or patients who are CD19 positive.
Is Tanja A Gruber, MD, PhD currently recruiting for clinical trials?
Yes, Tanja A Gruber, MD, PhD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Tanja A Gruber, MD, PhD has studied deeply?
Yes, Tanja A Gruber, MD, PhD has studied treatments such as Blinatumomab, Bortezomib, Vorinostat.
What is the best way to schedule an appointment with Tanja A Gruber, MD, PhD?
Apply for one of the trials that Tanja A Gruber, MD, PhD is conducting.
What is the office address of Tanja A Gruber, MD, PhD?
The office of Tanja A Gruber, MD, PhD is located at: Lucile Packard Children's Hospital Stanford University, Palo Alto, California 94304 United States. This is the address for their practice at the Lucile Packard Children's Hospital Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.